Therapeutic Potential of Vasopressin Receptor Antagonists

Author： Ali Farhan   Guglin Maya   Vaitkevicius Peter   Ghali Jalal K.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.6, 2007-01, pp. : 847-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D.   DeWald T.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

The therapeutic potential of vasopressin receptor antagonists in congestive heart failure

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 687-691

Informa Healthcare

Access to resources Recommend Favorite

Do vasopressin receptor type 2 antagonists have therapeutic potential in polycystic kidney diseases?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 431-434

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Paranjape S.B.   Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 825-834

Informa Healthcare

Access to resources Recommend Favorite